Nociceptive and pro-inflammatory effects of dimethylallyl pyrophosphate via TRPV4 activation

British Journal of Pharmacology

Volumn 166, Issue 4, 2012, Pages 1433-1443

  Bang, S ^a   Yoo, S ^a   Yang, T J ^a   Cho, H ^b   Hwang, S W ^a  

^a Korea University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

dimethylallyl pyrophosphate; keratinocyte; pain; sensory neuron; TRPV4

Indexed keywords

CALCIUM ION; CAMPHOR; DIMETHYLALLYLPYROPHOSPHATE; PYROPHOSPHORIC ACID DERIVATIVE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 3; VANILLOID RECEPTOR 4; VANILLOID RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; KERATINOCYTE; MALE; MOLECULAR IMAGING; MOUSE; NOCICEPTIVE PAIN; NOCICEPTIVE STIMULATION; NONHUMAN; PATCH CLAMP; PATHOPHYSIOLOGY; PAW EDEMA; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SENSORY NERVE CELL;

ANIMALS; BEHAVIOR, ANIMAL; CALCIUM SIGNALING; CELL LINE; CELLS, CULTURED; GANGLIA, SPINAL; HEMITERPENES; HUMANS; KERATINOCYTES; LIGANDS; MALE; MICE; NERVE TISSUE PROTEINS; NEURITIS; NEURONS; NOCICEPTIVE PAIN; ORGANOPHOSPHORUS COMPOUNDS; PAIN MEASUREMENT; PROTEIN ISOFORMS; RATS; RECOMBINANT PROTEINS; TRANSIENT RECEPTOR POTENTIAL CHANNELS; TRPV CATION CHANNELS;

EID: 84861303511     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.01884.x     Document Type: Article

References (49)

1. Alessandri-Haber N, Yeh JJ, Boyd AE, Parada CA, Chen X, Reichling DB, et al,. (2003). Hypotonicity induces TRPV4-mediated nociception in rat. Neuron 39: 497-511.
2. Alessandri-Haber N, Joseph E, Dina OA, Liedtke W, Levine JD, (2005). TRPV4 mediates pain-related behavior induced by mild hypertonic stimuli in the presence of inflammatory mediator. Pain 118: 70-79.
3. Alessandri-Haber N, Dina OA, Chen X, Levine JD, (2009). TRPC1 and TRPC6 channels cooperate with TRPV4 to mediate mechanical hyperalgesia and nociceptor sensitization. J Neurosci 29: 6217-6228.
4. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th Edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
5. Bandell M, Macpherson LJ, Patapoutian A, (2007). From chills to chilis: mechanisms for thermosensation and chemesthesis via thermoTRPs. Curr Opin Neurobiol 17: 490-497.
6. Bang S, Kim KY, Yoo S, Lee SH, Hwang SW, (2007a). Transient receptor potential V2 expressed in sensory neurons is activated by probenecid. Neurosci Lett 425: 120-125.
7. Bang S, Kim KY, Yoo S, Kim YG, Hwang SW, (2007b). Transient receptor potential A1 mediates acetaldehyde-evoked pain sensation. Eur J Neurosci 26: 2516-2523.
8. Bang S, Yoo S, Yang TJ, Cho H, Hwang SW, (2010a). Farnesyl pyrophosphate is a novel pain-producing molecule via specific activation of TRPV3. J Biol Chem 285: 19362-19371.
9. Bang S, Yoo S, Yang TJ, Cho H, Kim YG, Hwang SW, (2010b). Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. Br J Pharmacol 161: 707-720.
10. Bang S, Yoo S, Yang TJ, Cho H, Hwang SW, (2011). Isopentenyl pyrophosphate is a novel antinociceptive substance that inhibits TRPV3 and TRPA1 ion channels. Pain 152: 1156-1164.
11. Bang S, Yoo S, Yang TJ, Cho H, Hwang SW, (2012). 17(R)-resolvin D1 specifically inhibits TRPV3 leading to peripheral antinociception. Br J Pharmacol 165: 683-692.
12. Bessac BF, Sivula M, von Hehn CA, Escalera J, Cohn L, Jordt SE, (2008). TRPA1 is a major oxidant sensor in murine airway sensory neurons. J Clin Invest 118: 1899-1910.
13. Broad LM, Mogg AJ, Beattie RE, Ogden AM, Blanco MJ, Bleakman D, (2009). TRP channels as emerging targets for pain therapeutics. Expert Opin Ther Targets 13: 69-81.
14. Bruenger E, Rilling HC, (1988). Determination of isopentenyl diphosphate and farnesyl diphosphate in tissue samples with a comment on secondary regulation of polyisoprenoid biosynthesis. Anal Biochem 173: 321-327.
15. Bürk MR, Mori L, De Libero G, (1995). Human V gamma 9-V delta 2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites. Eur J Immunol 25: 2052-2058.
16. Cravatt BF, Saghatelian A, Hawkins EG, Clement AB, Bracey MH, Lichtman AH, (2004). Functional disassociation of the central and peripheral fatty acid amide signaling systems. Proc Natl Acad Sci U S A 101: 10821-10826.
17. Fisher AJ, Rosenstiel TN, Shirk MC, Fall R, (2001). Nonradioactive assay for cellular dimethylallyl diphosphate. Anal Biochem 292: 272-279.
18. Gevaert T, Vriens J, Segal A, Everaerts W, Roskams T, Talavera K, et al,. (2007). Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding. J Clin Invest 117: 3453-3462.
19. Grant AD, Cottrell GS, Amadesi S, Trevisani M, Nicoletti P, Materazzi S, et al,. (2007). Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice. J Physiol 578: 715-733.
20. Hartmannsgruber V, Heyken WT, Kacik M, Kaistha A, Grgic I, Harteneck C, et al,. (2007). Arterial response to shear stress critically depends on endothelial TRPV4 expression. PLoS ONE 2: e827.
21. Huang SM, Lee H, Chung MK, Park U, Yu YY, Bradshaw HB, et al,. (2008). Overexpressed transient receptor potential vanilloid 3 ion channels in skin keratinocytes modulate pain sensitivity via prostaglandin E2. J Neurosci 28: 13727-13737.
22. Kim KY, Bang S, Han S, Nguyen YH, Kang TM, Kang KW, et al,. (2008). TRP-independent inhibition of the phospholipase C pathway by natural sensory ligands. Biochem Biophys Res Commun 370: 295-300.
23. Lee H, Iida T, Mizuno A, Suzuki M, Caterina MJ, (2005). Altered thermal selection behavior in mice lacking transient receptor potential vanilloid 4. J Neurosci 25: 1304-1310.
24. Liedtke W, Friedman JM, (2003). Abnormal osmotic regulation in trpv4-/- mice. Proc Natl Acad Sci U S A 100: 13698-13703.
25. Liedtke W, Choe Y, Marti-Renom MA, Bell AM, Denis CS, Sali A, et al,. (2000). Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 103: 525-535.
26. Masuyama R, Vriens J, Voets T, Karashima Y, Owsianik G, Vennekens R, et al,. (2008). TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts. Cell Metab 8: 257-265.
27. Mizuno A, Matsumoto N, Imai M, Suzuki M, (2003). Impaired osmotic sensation in mice lacking TRPV4. Am J Physiol Cell Physiol 285: C96-101.
28. von Moos R, Strasser F, Gillessen S, Zaugg K, (2008). Metastatic bone pain: treatment options with an emphasis on bisphosphonates. Support Care Cancer 16: 1105-1115.
29. Moqrich A, Hwang SW, Earley TJ, Petrus MJ, Murray AN, Spencer KS, et al,. (2005). Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin. Science 307: 1468-1472.
30. Nilius B, Owsianik G, Voets T, Peters JA, (2007). Transient receptor potential cation channels in disease. Physiol Rev 87: 165-217.
31. Plant TD, Strotmann R, (2007). Trpv4. Handb Exp Pharmacol 179: 189-205.
32. Reiter B, Kraft R, Gunzel D, Zeissig S, Schulzke JD, Fromm M, et al,. (2006). TRPV4-mediated regulation of epithelial permeability. FASEB J 20: 1802-1812.
33. Rock MJ, Prenen J, Funari VA, Funari TL, Merriman B, Nelson SF, et al,. (2008). Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia. Nat Genet 40: 999-1003.
34. Ryu JJ, Yoo S, Kim KY, Park JS, Bang S, Lee SH, et al,. (2010). Laser modulation of heat and capsaicin receptor TRPV1 leads to thermal antinociception. J Dent Res 89: 1455-1460.
35. Saisho Y, Morimoto A, Umeda T, (1997). Determination of farnesyl pyrophosphate in dog and human plasma by high-performance liquid chromatography with fluorescence detection. Anal Biochem 252: 89-95.
36. Sharma A, Williams K, Raja SN, (2006). Advances in treatment of complex regional pain syndrome: recent insights on a perplexing disease. Curr Opin Anaesthesiol 19: 566-572.
37. Smith PL, Maloney KN, Pothen RG, Clardy J, Clapham DE, (2006). Bisandrographolide from Andrographis paniculata activates TRPV4 channels. J Biol Chem 281: 29897-29904.
38. Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR, et al,. (2003). ANKTM1, TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112: 819-829.
39. Strotmann R, Harteneck C, Nunnenmacher K, Schultz G, Plant TD, (2000). OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity. Nat Cell Biol 2: 695-702.
40. Suzuki M, Mizuno A, Kodaira K, Imai M, (2003). Impaired pressure sensation in mice lacking TRPV4. J Biol Chem 278: 22664-22668.
41. Tabuchi K, Suzuki M, Mizuno A, Hara A, (2005). Hearing impairment in TRPV4 knockout mice. Neurosci Lett 382: 304-308.
42. Tan PH, Chia YY, Chow LH, Chen JJ, Yang LC, Hung KC, et al,. (2010). Gene knockdown of the N-methyl-D-aspartate receptor NR1 subunit with subcutaneous small interfering RNA reduces inflammation-induced nociception in rats. Anesthesiology 112: 1482-1493.
43. Tanaka Y, Morita CT, Nieves E, Brenner MB, Bloom BR, (1995). Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature 375: 155-158.
44. Vergnolle N, Cenac N, Altier C, Cellars L, Chapman K, Zamponi GW, et al,. (2010). A role for transient receptor potential vanilloid 4 in tonicity-induced neurogenic inflammation. Br J Pharmacol 159: 1161-1173.
45. Vriens J, Appendino G, Nilius B, (2009). Pharmacology of vanilloid transient receptor potential cation channels. Mol Pharmacol 75: 1262-1279.
46. Watanabe H, Davis JB, Smart D, Jerman JC, Smith GD, Hayes P, et al,. (2002). Activation of TRPV4 Channels (hVRL-2/mTRP12) by Phorbol Derivatives. J Biol Chem 277: 13569-13577.
47. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B, (2003). Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 424: 434-438.
48. Willette RN, Bao W, Nerurkar S, Yue TL, Doe CP, Stankus G, et al,. (2008). Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2. J Pharmacol Exp Ther 326: 443-452.
49. Wilson SR, Gerhold KA, Bifolck-Fisher A, Liu Q, Patel KN, Dong X, et al,. (2011). TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch. Nat Neurosci 14: 595-602.